Cargando…
Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection
BACKGROUND: Recent advances in circulating cell-free DNA (cfDNA) analysis from biofluids have opened new avenues for liquid biopsy (LB). However, current cfDNA LB assays are limited by the availability of existing information on established genotypes associated with tumor tissues. Certain cancers pr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371094/ https://www.ncbi.nlm.nih.gov/pubmed/37503289 http://dx.doi.org/10.21203/rs.3.rs-3154388/v1 |
_version_ | 1785078080758349824 |
---|---|
author | Swarup, Neeti Cheng, Jordan Choi, Irene Heo, You Jeong Kordi, Misagh Li, Feng Aziz, Mohammad Chia, David Wei, Fang Elashoff, David Zhang, Liying Kim, Sung Kim, Yong Wong, David T.W. |
author_facet | Swarup, Neeti Cheng, Jordan Choi, Irene Heo, You Jeong Kordi, Misagh Li, Feng Aziz, Mohammad Chia, David Wei, Fang Elashoff, David Zhang, Liying Kim, Sung Kim, Yong Wong, David T.W. |
author_sort | Swarup, Neeti |
collection | PubMed |
description | BACKGROUND: Recent advances in circulating cell-free DNA (cfDNA) analysis from biofluids have opened new avenues for liquid biopsy (LB). However, current cfDNA LB assays are limited by the availability of existing information on established genotypes associated with tumor tissues. Certain cancers present with a limited list of established mutated cfDNA biomarkers, and thus, nonmutated cfDNA characteristics along with alternative biofluids are needed to broaden the available cfDNA targets for cancer detection. Saliva is an intriguing and accessible biofluid that has yet to be fully explored for its clinical utility for cancer detection. METHODS: In this report, we employed a low-coverage single stranded (ss) library NGS pipeline “Broad-Range cell-free DNA-Seq” (BRcfDNA-Seq) using saliva to comprehensively investigate the characteristics of salivary cfDNA (ScfDNA). The identification of cfDNA features has been made possible by applying novel cfDNA processing techniques that permit the incorporation of ultrashort, ss, and jagged DNA fragments. As a proof of concept using 10 gastric cancer (GC) and 10 noncancer samples, we examined whether ScfDNA characteristics, including fragmentomics, end motif profiles, microbial contribution, and human chromosomal mapping, could differentiate between these two groups. RESULTS: Individual and integrative analysis of these ScfDNA features demonstrated significant differences between the two cohorts, suggesting that disease state may affect the ScfDNA population by altering nuclear cleavage or the profile of contributory organism cfDNA to total ScfDNA. We report that principal component analysis integration of several aspects of salivary cell-free DNA fragmentomic profiles, genomic element profiles, end-motif sequence patterns, and distinct oral microbiome populations can differentiate the two populations with a p value of < 0.0001 (PC1). CONCLUSION: These novel features of ScfDNA characteristics could be clinically useful for improving saliva-based LB detection and the eventual monitoring of local or systemic diseases. |
format | Online Article Text |
id | pubmed-10371094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-103710942023-07-27 Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection Swarup, Neeti Cheng, Jordan Choi, Irene Heo, You Jeong Kordi, Misagh Li, Feng Aziz, Mohammad Chia, David Wei, Fang Elashoff, David Zhang, Liying Kim, Sung Kim, Yong Wong, David T.W. Res Sq Article BACKGROUND: Recent advances in circulating cell-free DNA (cfDNA) analysis from biofluids have opened new avenues for liquid biopsy (LB). However, current cfDNA LB assays are limited by the availability of existing information on established genotypes associated with tumor tissues. Certain cancers present with a limited list of established mutated cfDNA biomarkers, and thus, nonmutated cfDNA characteristics along with alternative biofluids are needed to broaden the available cfDNA targets for cancer detection. Saliva is an intriguing and accessible biofluid that has yet to be fully explored for its clinical utility for cancer detection. METHODS: In this report, we employed a low-coverage single stranded (ss) library NGS pipeline “Broad-Range cell-free DNA-Seq” (BRcfDNA-Seq) using saliva to comprehensively investigate the characteristics of salivary cfDNA (ScfDNA). The identification of cfDNA features has been made possible by applying novel cfDNA processing techniques that permit the incorporation of ultrashort, ss, and jagged DNA fragments. As a proof of concept using 10 gastric cancer (GC) and 10 noncancer samples, we examined whether ScfDNA characteristics, including fragmentomics, end motif profiles, microbial contribution, and human chromosomal mapping, could differentiate between these two groups. RESULTS: Individual and integrative analysis of these ScfDNA features demonstrated significant differences between the two cohorts, suggesting that disease state may affect the ScfDNA population by altering nuclear cleavage or the profile of contributory organism cfDNA to total ScfDNA. We report that principal component analysis integration of several aspects of salivary cell-free DNA fragmentomic profiles, genomic element profiles, end-motif sequence patterns, and distinct oral microbiome populations can differentiate the two populations with a p value of < 0.0001 (PC1). CONCLUSION: These novel features of ScfDNA characteristics could be clinically useful for improving saliva-based LB detection and the eventual monitoring of local or systemic diseases. American Journal Experts 2023-07-14 /pmc/articles/PMC10371094/ /pubmed/37503289 http://dx.doi.org/10.21203/rs.3.rs-3154388/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Swarup, Neeti Cheng, Jordan Choi, Irene Heo, You Jeong Kordi, Misagh Li, Feng Aziz, Mohammad Chia, David Wei, Fang Elashoff, David Zhang, Liying Kim, Sung Kim, Yong Wong, David T.W. Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection |
title | Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection |
title_full | Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection |
title_fullStr | Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection |
title_full_unstemmed | Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection |
title_short | Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection |
title_sort | multi-faceted attributes of salivary cell-free dna as liquid biopsy biomarkers for gastric cancer detection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371094/ https://www.ncbi.nlm.nih.gov/pubmed/37503289 http://dx.doi.org/10.21203/rs.3.rs-3154388/v1 |
work_keys_str_mv | AT swarupneeti multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT chengjordan multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT choiirene multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT heoyoujeong multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT kordimisagh multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT lifeng multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT azizmohammad multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT chiadavid multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT weifang multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT elashoffdavid multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT zhangliying multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT kimsung multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT kimyong multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection AT wongdavidtw multifacetedattributesofsalivarycellfreednaasliquidbiopsybiomarkersforgastriccancerdetection |